Delivery Order SPE2DR25D1103-SPE2DR26FF106
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a Delivery Order valued at $6,163.49 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) on January 22, 2026, with completion expected by January 23, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of Cencora, Inc. and serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,566.41 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units), with an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,931.19 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) on February 2, 2026, with an ultimate completion date of February 3, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $9,468.39 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of CAPLYTA 21 mg capsules (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) valued at $4,244.31 under a firm fixed-price contract type. The award was made on May 6, 2025, with an ultimate completion date of May 7, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $11,458.54 to AmerisourceBergen Drug Corp for CAPLYTA 42 MG capsules (30-unit supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 18, 2025. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed-price contract valued at $4,207.95, with an ultimate completion date of January 12, 2026. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $10,244.42 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units). The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,979.16 delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-unit supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military...
- The Defense Logistics Agency awarded a delivery order valued at $3,372.23 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) with a completion date of January 29, 2026. This non-competitive, firm fixed-price delivery order was issued on January 28, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare...